Relaxin: Molecular mechanisms of action in the reversal of fibrosis

  • Summers, Roger (Primary Chief Investigator (PCI))
  • Gao, Xiao-Ming (Chief Investigator (CI))
  • Judkins, Courtney (Chief Investigator (CI))
  • Bathgate, Ross (Partner Investigator (PI))
  • Du, Xiao-Jun (Partner Investigator (PI))
  • Samuel, Chrishan S (Partner Investigator (PI))
  • Tang, Mimi L K (Partner Investigator (PI))
  • Tregear, Geoffrey W. (Partner Investigator (PI))

Project: Research

Project Description

Defects in relaxin and relaxin receptors are increasingly implicated as a cause of fibrosis which is associated with many disease processes. This study will examine the molecular mechanisms linking relaxin and fibrosis and will determine whether relaxin can be used to reverse the condition.
StatusFinished
Effective start/end date1/01/0531/12/07

Funding

  • Australian Research Council (ARC): AUD100,074.00
  • Australian Research Council (ARC): AUD72,444.00
  • Australian Research Council (ARC): AUD72,444.00
  • Australian Research Council (ARC)
  • Australian Research Council (ARC): AUD202,482.00
  • BASS Medical Inc: AUD160,566.00